As part of a major restructure, Britain’s largest drugs company GlaxoSmithKline (GSK) is to slash 4,000 positions, according to The Sunday Times.According to press reports, the job losses are part of plans to shift its focus to emerging markets, such as China which has greater potential to increase sales growth.The company has a global workforce [...]
More: GSK to axe 4,000 jobs as it shifts focus